BioCardia logo

BioCardia

BCDA | NASDAQ
Chart Builder DCF Calculator
$0.79
-$0.04 (-4.93%)
At close: Nov 16, 2026, 4:00 PM ET
$0.81
+$0.02 (+3.16%)
After-hours: Nov 16, 2026, 7:43 PM ET
-4.93%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
35.2
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #649/1021 (Top 64%)

Key Statistics

Market Data

Market Cap $11.96M
1D Range
0.75 0.85
52W Range
0.75 1.47

Valuation (TTM)

PE -1.23
PB 14.32
EV/EBITDA -1.37

Valuation (NTM)

Forward PE N/A
Forward PEG 0.03
Price Target $25.00
Loading financial charts...

Profile

BioCardia, Inc. is a pioneering clinical-stage company dedicated to regenerative medicine, focusing on the development of advanced cellular and cell-derived therapies for a range of cardiac and respir...

Sector Healthcare
Industry Biotechnology
Employees 17
IPO Date Nov 13, 1996
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
1
Consensus
Buy
Price Target
$25.00
Upside
+3064.56%
Buy (1)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.